Showing results 18 to 29 of 29
< previous
| Issue Date | Title | Author(s) |
| 2021-09-15 | Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease. | Lu, Z; Van Eeckhoutte, HP; Liu, G; Nair, PM; Jones, B; Gillis, CM; Nalkurthi, BC; Verhamme, F; Buyle-Huybrecht, T; Vandenabeele, P; Vanden Berghe, T; Brusselle, GG; Horvat, JC; Murphy, JM; Wark, PA; Bracke, KR; Fricker, M; Hansbro, PM |
| 2013-01-01 | A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis | Beckett, EL; Stevens, RL; Jarnicki, AG; Kim, RY; Hanish, I; Hansbro, NG; Deane, A; Keely, S; Horvat, JC; Yang, M; Oliver, BG; Van Rooijen, N; Inman, MD; Adachi, R; Soberman, RJ; Hamadi, S; Wark, PA; Foster, PS; Hansbro, PM |
| 2018-05-01 | Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches | Reid, AT; Veerati, PC; Gosens, R; Bartlett, NW; Wark, PA; Grainge, CL; Stick, SM; Kicic, A; Moheimani, F; Hansbro, PM; Knight, DA |
| 2019-10-01 | RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses | Hayman, TJ; Hsu, AC; Kolesnik, TB; Dagley, LF; Willemsen, J; Tate, MD; Baker, PJ; Kershaw, NJ; Kedzierski, L; Webb, AI; Wark, PA; Kedzierska, K; Masters, SL; Belz, GT; Binder, M; Hansbro, PM; Nicola, NA; Nicholson, SE |
| 2017-08-01 | Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma | Kim, RY; Pinkerton, JW; Essilfie, AT; Robertson, AAB; Baines, KJ; Brown, AC; Mayall, JR; Ali, MK; Starkey, MR; Hansbro, NG; Hirota, JA; Wood, LG; Simpson, JL; Knight, DA; Wark, PA; Gibson, PG; O'Neill, LAJ; Cooper, MA; Horvat, JC; Hansbro, PM |
| 2019-01-01 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease | Donovan, C; Starkey, MR; Kim, RY; Rana, BMJ; Barlow, JL; Jones, B; Haw, TJ; Mono Nair, P; Budden, K; Cameron, GJM; Horvat, JC; Wark, PA; Foster, PS; McKenzie, ANJ; Hansbro, PM |
| 2020-10-01 | SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro | Hsu, AC-Y; Wang, G; Reid, AT; Veerati, PC; Pathinayake, PS; Daly, K; Mayall, JR; Hansbro, PM; Horvat, JC; Wang, F; Wark, PA |
| 2017-02-14 | Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling | Kedzierski, L; Tate, MD; Hsu, AC; Kolesnik, TB; Linossi, EM; Dagley, L; Dong, Z; Freeman, S; Infusini, G; Starkey, MR; Bird, NL; Chatfield, SM; Babon, JJ; Huntington, N; Belz, G; Webb, A; Wark, PA; Nicola, NA; Xu, J; Kedzierska, K; Hansbro, PM; Nicholson, SE |
| 2015-05 | Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease. | Hsu, AC-Y; Starkey, MR; Hanish, I; Parsons, K; Haw, TJ; Howland, LJ; Barr, I; Mahony, JB; Foster, PS; Knight, DA; Wark, PA; Hansbro, PM |
| 2021-01 | The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders. | Chong, WC; Shastri, MD; Peterson, GM; Patel, RP; Pathinayake, PS; Dua, K; Hansbro, NG; Hsu, AC; Wark, PA; Shukla, SD; Johansen, MD; Schroder, K; Hansbro, PM |
| 2023-11-14 | TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase. | Liu, G; Haw, TJ; Starkey, MR; Philp, AM; Pavlidis, S; Nalkurthi, C; Nair, PM; Gomez, HM; Hanish, I; Hsu, AC; Hortle, E; Pickles, S; Rojas-Quintero, J; Estepar, RSJ; Marshall, JE; Kim, RY; Collison, AM; Mattes, J; Idrees, S; Faiz, A; Hansbro, NG; Fukui, R; Murakami, Y; Cheng, HS; Tan, NS; Chotirmall, SH; Horvat, JC; Foster, PS; Oliver, BG; Polverino, F; Ieni, A; Monaco, F; Caramori, G; Sohal, SS; Bracke, KR; Wark, PA; Adcock, IM; Miyake, K; Sin, DD; Hansbro, PM |
| 2008-03 | Understanding the mechanisms of viral induced asthma: new therapeutic directions. | Hansbro, NG; Horvat, JC; Wark, PA; Hansbro, PM |
